Jill Feldman on Diversifying the Criteria for Inclusion in Clinical Trials

February 08, 2021 By The ASCO Post Staff

Jill Feldman, a patient advocate and lung cancer survivor, discusses the current challenges and potential solutions to including more people of color and those in underserved communities in clinical trial research (Abstract PL04.06).

Related Content